Diabetic Cardiomyopathy: baseline Characteristics of patients enrolled into the ARISE-HF trial

被引：0
|
作者：
Del Prato, S. [1 ]
Rosenstock, J. [2 ]
Butler, J. [3 ]
Ezekowitz, J. [4 ]
Ibrahim, N. [5 ]
Lam, C. [6 ]
Marwick, T. [7 ]
Perfetti, R. [8 ]
Tang, W. H. Wilson [9 ]
Urbinati, A. Alessia [8 ]
Zannad, F. [10 ]
Januzzi, J. [11 ]
机构：
[1] Univ Pisa, Pisa, Italy
[2] Dallas Diabet Res Ctr, Dallas, TX USA
[3] Baylor Scott & White Hlth, Dallas, TX USA
[4] Univ Alberta, Edmonton, AB, Canada
[5] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
[6] Duke NUS Grad Med Sch Singapore, Singapore, Singapore
[7] Baker Heart & Diabet Inst, Melbourne, Australia
[8] Appl Therapeut, New York, NY USA
[9] Cleveland Clin, Cleveland, OH USA
[10] Univ Lorraine, Nancy, France
[11] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [21] Baseline characteristics of patients enrolled in the FIBRONEER-ILD trial of nerandomilast (BI 1015550)
    Maher, Toby M.
    Assassi, Shervin
    Azuma, Arata
    Cottin, Vincent
    Hoffmann-Vold, Anna-Maria
    Kreuter, Michael
    Oldham, Justin M.
    Richeldi, Luca
    Valenzuela, Claudia
    Wijsenbeek, Marlies S.
    Coeck, Carl
    Schlosser, Arno
    Wachtlin, Daniel
    Martinez, Fernando J.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [22] Baseline characteristics of patients enrolled in EXCELS: a cohort study
    Long, Aidan A.
    Fish, James E.
    Rahmaoui, Abdelkader
    Miller, Mary K.
    Bradley, Mary S.
    Taki, Hassan N.
    Demeo, Anthony N.
    Tilles, Stephen A.
    Szefler, Stanley J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (03) : 212 - 219
  • [23] Baseline characteristics of PKU patients enrolled in the PKUDOS registry
    Burton, B. K.
    Longo, N.
    Arnold, G. L.
    Enns, G. M.
    Andersson, H. C.
    Mofidi, S.
    Peck, D.
    Prado, B. C.
    Pridjian, G.
    Waisbren, S.
    White, D.
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (03) : 273 - 273
  • [24] Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial
    Fishbein, Nathan S.
    Vranceanu, Ana-Maria
    Mace, Ryan A.
    JOURNAL OF NEURO-ONCOLOGY, 2022, 159 (03) : 637 - 646
  • [25] Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial
    Nathan S. Fishbein
    Ana-Maria Vranceanu
    Ryan A. Mace
    Journal of Neuro-Oncology, 2022, 159 : 637 - 646
  • [26] Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction DELIVER Trial
    Solomon, Scott D.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    de Boer, Rudolf A.
    DeMets, David
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Shah, Sanjiv J.
    Belohlavek, Jan
    Chiang, Chern-En
    Borleffs, C. Jan Willem
    Comin-Colet, Josep
    Dobreanu, Dan
    Drozdz, Jaroslaw
    Fang, James C.
    Alcocer Gamba, Marco Antonio
    Al Habeeb, Waleed
    Han, Yaling
    Cabrera Honorio, Jose Walter
    Janssens, Stefan P.
    Katova, Tsvetana
    Kitakaze, Masafumi
    Merkely, Bela
    O'Meara, Eileen
    Kerr Saraiva, Jose Francisco
    Tereschenko, Sergey N.
    Thierer, Jorge
    Vardeny, Orly
    Verma, Subodh
    Vinh, Pham Nguyen
    Wilderang, Ulrica
    Zaozerska, Natalia
    Lindholm, Daniel
    Petersson, Magnus
    McMurray, John J. V.
    JACC-HEART FAILURE, 2022, 10 (03) : 184 - 197
  • [27] Baseline characteristics of patients enrolled in the Canadian Fabry Disease Initiative
    Sirrs, S.
    Clarke, J. T. R.
    Bichet, D. G.
    Casey, R.
    Lemoine, K.
    Flowerdew, G.
    Sinasac, D. S.
    West, M. L.
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (04) : 367 - 373
  • [28] Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial
    Solomon, Scott D.
    Rizkala, Adel R.
    Lefkowitz, Martin P.
    Shi, Victor C.
    Gong, JianJian
    Anavekar, Nagesh
    Anker, Stefan D.
    Arango, Juan L.
    Arenas, Jose L.
    Atar, Dan
    Ben-Gal, Turia
    Boytsov, Sergey A.
    Chen, Chen-Huan
    Chopra, Vijay K.
    Cleland, John
    Comin-Colet, Josep
    Duengen, Hans-Dirk
    Echeverria Correa, Luis E.
    Filippatos, Gerasimos
    Flammer, Andreas J.
    Galinier, Michel
    Godoy, Armando
    Goncalvesova, Eva
    Janssens, Stefan
    Katova, Tzvetana
    Kober, Lars
    Lelonek, Malgorzata
    Linssen, Gerard
    Lund, Lars H.
    O'Meara, Eileen
    Merkely, Bela
    Milicic, Davor
    Oh, Byung-Hee
    Perrone, Sergio V.
    Ranjith, Naresh
    Saito, Yoshihiko
    Saraiva, Jose F.
    Shah, Sanjiv
    Seferovic, Petar M.
    Senni, Michele
    Sibulo, Antonio S., Jr.
    Sim, David
    Sweitzer, Nancy K.
    Taurio, Jyrki
    Vinereanu, Dragos
    Vrtovec, Bojan
    Widimsky, Jiri
    Yilmaz, Mehmet B.
    Zhou, Jingmin
    Zweiker, Robert
    CIRCULATION-HEART FAILURE, 2018, 11 (07)
  • [29] BASELINE CHARACTERISTICS OF ALL PATIENTS ENROLLED IN A PHASE II CLINICAL TRIAL ASSESSING THE EFFICACY AND SAFETY OF NINTEDANIB IN LYMPHANGIOLEIOMYOMATOSIS
    Cassandro, R.
    Harari, S.
    Caminati, A.
    Elia, D.
    Specchia, C.
    CHEST, 2020, 157 (06) : 160A - 160A
  • [30] Progressive, metastatic medullary thyroid cancer: Baseline symptoms and disease characteristics among patients enrolled in the EXAM trial
    Schoffski, P.
    Cohen, E.
    Bentzien, F.
    Sherman, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S745 - S745
12345